|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02659 BAO PHARMA-B
Nominal 
89.800 -2.400 (-2.603%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 |
| Property, plant, equip. & others | 680,696 | 9.493% | 621,681 | 531,215 |
| Land & other Lease Assets | 53,561 | -3.408% | 55,451 | 54,207 |
| Intangible Assets | 11,690 | -5.091% | 12,317 | 12,565 |
| Interests in Asso. & JCEs | 10,814 | 38.145% | 7,828 | 8,437 |
| Other Non-current Assets | 97,062 | 23573.659% | 410 | 1,311 |
| 853,823 | 22.379% | 697,687 | 607,735 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Inventories | 6,248 | 32.513% | 4,715 | 8,072 | |
| Trade Receivables | 98 | -30.496% | 141 | 2,000 | |
| Cash & Bank Balances | 1,241,609 | 136.877% | 524,158 | 321,671 | |
| Other Current Assets | 115,201 | -15.644% | 136,566 | 34,402 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | |
| 1,363,156 | 104.807% | 665,580 | 366,145 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||
| Trade Payables | 8 | -- | 0 | 0 | ||
| S-T Debt & Leases | 115,565 | 62.472% | 71,129 | 66,035 | ||
| Other Current Liabilities | 215,079 | 71.923% | 125,102 | 80,786 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | ||
| 330,652 | 68.501% | 196,231 | 146,821 | |||
| Net Current Assets | 1,032,504 | 119.986% | 469,349 | 219,324 | ||
| Total Assets Less Current Liabilities | 1,886,327 | 61.634% | 1,167,036 | 827,059 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||||
| L-T Debt & Leases | 199,430 | 48.684% | 134,130 | 45,080 | |||
| Other Non-current Liabilities | 94,923 | 156.341% | 37,030 | 32,853 | |||
| 294,353 | 71.975% | 171,160 | 77,933 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||||
| Share Capital | 65,196 | 13.862% | 57,259 | 52,046 | ||||
| Reserves | 1,526,778 | 62.663% | 938,617 | 697,080 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| Shareholders' Funds | 1,591,974 | 59.857% | 995,876 | 749,126 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| 1,591,974 | 59.857% | 995,876 | 749,126 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Commitments | -- | -- | 82,001 | 101,880 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -395,302 |
| %Change | 8.470% |
| EPS / (LPS) | RMB -1.360 |
| NBV Per Share (¥) | RMB 4.884 |